NASDAQ •
Healthcare •
Diagnostics & Research •
Quote as of 05/22/2026
Company Profile
IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization29,402 mln
Float139 mln
Earnings Date07/30/2026
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
0.25
Highly suspicious
1-Year Forecast
261
Strong upside
Relative Strength
86
/ 100
Strongly outperforming
Debt / Equity
0.14
Very low leverage
ROE
-15.66
Negative
Business Description
Founded in 2003 and based in Austin, Texas, Natera develops and sells genetic testing services for use across oncology, women's health, and organ transplant care. Its tests help detect cancer recurrence, screen for hereditary conditions, support prenatal care, and monitor kidney and transplant health. The company works with hospitals, physician practices, research labs, and pharmaceutical companies, and also offers cloud-based software that allows partner labs to distribute its testing under license.
